iShares 1 3 Year Treasury Bond ETF vs Tenet Healthcare Corporation — how do they compare? iShares 1 3 Year Treasury Bond ETF trades at $81.25 (market cap $26.63B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: iShares 1 3 Year Treasury Bond ETF is the larger of the two by market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares 1 3 Year Treasury Bond ETF for 63 Days and Tenet Healthcare Corporation for 15 Days on average.
| SHY | THC | |
|---|---|---|
Market Cap | $26.63B | $20.92B |
Volume | 4,081,431 | 455,764 |
Sector | Fixed Income | Health |
52-Week High | $83.18 | $280.77 |
52-Week Low | $81.05 | $161.37 |
Typical Hold Time | 63 Days | 15 Days |
Enterprise Value | — | $32.00B |
Signals from Pluang's Aura AI — not financial advice
SHY is trading at $81.16 with minimal daily movement (+0.04%), showing stability amid broader bond market volatility. The technical picture remains bearish with moving averages signaling downward pressure, while oscillators suggest neutral momentum. Recent corporate actions include consistent dividend payments, with the latest being $0.24 per share. The fund operates in a challenging interest rate environment where short-term bond ETFs face both opportunities and headwinds from Federal Reserve policy shifts.
The outlook for SHY is mixed, with potential benefits from rising short-term yields but significant pressure from the ongoing bond market selloff. Investment opportunities include exposure to increasing interest rates with limited duration risk, while risks encompass continued bond market volatility and macroeconomic uncertainty driving yields higher. The fund's stability and dividend consistency provide some defensive characteristics in turbulent markets.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →